Summary
1.8428 0.0428(2.3778%)09/27/2024
PharmaCyte Biotech Inc (PMCB)
PharmaCyte Biotech Inc (PMCB)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
2.9382 | 6.2133 | 24.5135 | -11.4166 | -24.4754 | -11.8278 | 0.0000 | 34,025.9259 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 1.8428 | |
Open | 1.7800 | |
High | 1.9500 | |
Low | 1.7800 | |
Volume | 17,882 | |
Change | 0.0526 | |
Change % | 2.9382 | |
Avg Volume (20 Days) | 35,242 | |
Volume/Avg Volume (20 Days) Ratio | 0.51 | |
52 Week Range | 1.39 - 2.56 | |
Price vs 52 Week High | -28.02% | |
Price vs 52 Week Low | 32.58% | |
Range | 3.5281 | |
Gap Up/Down | -0.0987 |
Fundamentals | ||
Market Capitalization (Mln) | 14 | |
EBIDTA | 0 | |
PE Ratio | 0.0000 | |
PEG Ratio | 0.0000 | |
WallStreet Target Price | 0.0000 | |
Book Value | 0.0040 | |
Earnings Per Share | -0.0030 | |
EPS Estimate Current Quarter | 0.0000 | |
EPS Estimate Next Quarter | 0.0000 | |
EPS Estimate Current Year | 0.0000 | |
EPS Estimate Next Year | 0.0000 | |
Diluted EPS (TTM) | -0.0020 | |
Revenues | ||
Profit Marging | 0.0000 | |
Operating Marging (TTM) | 0.0000 | |
Return on asset (TTM) | -0.3026 | |
Return on equity (TTM) | -0.5401 | |
Revenue TTM | 0 | |
Revenue per share TTM | 0.0000 | |
Quarterly Revenue Growth (YOY) | 0.0000 | |
Quarterly Earnings Growth (YOY) | 0.0000 | |
Gross Profit (TTM) | 0 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 0.0000 | |
Forward PE | 0.0000 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 4.9085 | |
Revenue Enterprise Value | 0.0000 | |
EBITDA Enterprise Value | 0.0000 | |
Shares | ||
Shares Outstanding | 2,334,810,112 | |
Shares Float | 2,277,070,544 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 2.27 | |
Institutions (%) | 0.02 |